"Bobby Parrish is the expert behind FlavCity, specializing in healthy, budget-friendly recipes and clean eating tips. Visit ...

Medically reviewed by Josephine Hessert, DO A sore throat is usually not cause for concern, and the discomfort typically ...

People can arrange deliveries every 4, 6, or 8 weeks. “I used Cornbread’s CBD menthol lotion on sore muscles, after hard gym days and long days sitting at a computer. “The lotion worked for ...

Strep throat symptoms include a sore throat and a fever, as well as throat swelling, a swollen uvula, or swollen tonsils. Healthcare providers use several tests to diagnose strep throat. It is treated ...

True Recurrent Strep A true recurrent strep infection has the following characteristics: Classic strep symptoms (sore throat, fever, tonsils that are red and swollen, swollen lymph nodes) Symptoms ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

Testing for step throat and ear infections is now available at select pharmacies in Saskatchewan. The new services are part of a provincial pilot project. Eleven Saskatchewan pharmacies have ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...